Mohamed N Amin
Overview
Explore the profile of Mohamed N Amin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
El-Hawary S, Mohammed R, Tawfike A, Lithy N, AbouZid S, Amin M, et al.
Metabolites
. 2021 Jan;
11(1).
PMID: 33383761
is a large genus of flowering plants with a great diversity in metabolic pattern. Testing the cytotoxic potential of fifteen species revealed highest activity of L. against CACO2 cell line...
12.
Samra Y, Amin M, Said E
Int Immunopharmacol
. 2020 Nov;
90:107125.
PMID: 33199237
Purpose: Cardiotoxicity is one of the most commonly encountered adverse effects observed alongside the therapeutic use of doxorubicin (DOX), thus curbing its therapeutic utility. Methods: The current study was conducted...
13.
Shady N, Abdelmohsen U, AboulMagd A, Amin M, Ahmed S, Fouad M, et al.
Nat Prod Res
. 2020 Sep;
35(24):6093-6098.
PMID: 32975127
The chemical profile of the butanol fraction of the Red Sea sponge sp. was explored using liquid chromatography coupled with high-resolution mass spectrometry and identified compounds (). Moreover, cytotoxic activities...
14.
Elshazli R, Toraih E, Elgaml A, El-Mowafy M, El-Mesery M, Amin M, et al.
PLoS One
. 2020 Aug;
15(8):e0238160.
PMID: 32822430
Objective: Evidence-based characterization of the diagnostic and prognostic value of the hematological and immunological markers related to the epidemic of Coronavirus Disease 2019 (COVID-19) is critical to understand the clinical...
15.
Zabad I, Amin M, El-Shishtawy M
Life Sci
. 2019 Nov;
239:117088.
PMID: 31759039
Aims: Diabetic nephropathy (DN) is a common chronic microvascular complication of both types of diabetes mellitus, which leads to renal dysfunction and subsequent need of dialysis and organ transplantation. Advanced...
16.
Amin M, Mosa A, El-Shishtawy M
Int J Biomed Sci
. 2013 May;
7(3):191-200.
PMID: 23675236
Advanced glycation end products (AGEs) are complex, heterogenous molecules generated by glycation and oxidation of proteins in vivo, which are thought to markedly increase in diabetic patients. One of the...